Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Detection of Interleukin-6 and Insulin-like Growth Factor Binding Protein-1 Total and Native (Premaquick) for the Prediction of Delivery in Women With Threatened Preterm Labor

NCT03608995 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.

NCT NCT03608995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03608995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Detection of Interleukin-6 and Insulin-like Growth Factor Binding Protein-1 Total and Native (Premaquick) for the Prediction of Delivery in Women With Threatened Preterm Labor
Lead sponsor
University Hospital, Clermont-Ferrand
Phase
Not applicable
Overall status
Completed
Start date
August 21, 2018
Completion date
December 16, 2020
Enrollment
221 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomarkers, immunochromatographic assay, predictive value of tests, preterm delivery, preterm labor